Jason Gardner
2017 - Dianthus Therapeutics
In 2017, Jason Gardner earned a total compensation of $599.4K as President and Chief Executive Officer at Dianthus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $194,400 |
|---|---|
| Salary | $405,000 |
| Total | $599,400 |
Gardner received $405K in salary, accounting for 68% of the total pay in 2017.
Gardner also received $194.4K in non-equity incentive plan.
Rankings
In 2017, Jason Gardner's compensation ranked 11,203rd out of 14,666 executives tracked by ExecPay. In other words, Gardner earned more than 23.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,203 out of 14,666 | 24th |
Division Manufacturing | 4,390 out of 5,772 | 24th |
Major group Chemicals And Allied Products | 1,593 out of 2,075 | 23rd |
Industry group Drugs | 1,312 out of 1,731 | 24th |
Industry Pharmaceutical Preparations | 1,026 out of 1,333 | 23rd |
Source: SEC filing on April 25, 2019.
News
Dianthus Therapeutics Former President, Chief Financial and Operating Officer Stephen Mahoney's 2023 pay jumps 48% to $1.7M
April 11, 2024
Dianthus Therapeutics CEO Jason Gardner's 2021 pay falls 28% to $2.2M
May 2, 2022
Marqeta CEO Jason Gardner's 2021 pay jumps 7,132% to $224M
April 25, 2022
Dianthus Therapeutics CEO Jason Gardner's 2020 pay jumps 88% to $3.1M
April 21, 2021
Dianthus Therapeutics CEO Jason Gardner's 2018 pay jumps 692% to $4.7M
April 25, 2019